ID

19345

Descripción

The Effect of a Weight Management Program During Treatment With Olanzapine; ODM derived from: https://clinicaltrials.gov/show/NCT00169702

Link

https://clinicaltrials.gov/show/NCT00169702

Palabras clave

Versiones (1)
  1. 19/12/16 19/12/16 -
Subido en

19 de diciembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00169702

Inglés

Eligibility Schizophrenia NCT00169702

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv) criteria for schizophrenia
Descripción

Schizophrenia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036341
ages between 18 and 65
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
weight gain of at least 1.5 kg in the first 4 weeks
Descripción

Weight Gain Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0043094
UMLS CUI [1,2]
C1265611
a sufficient understanding to participate adequately in the weight management program
Descripción

Weight maintenance regimen Participation Comprehension

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920298
UMLS CUI [1,2]
C0679823
UMLS CUI [1,3]
C0162340
patients must agree to cooperate with all tests and examinations required by the protocol.
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
each patient must understand the nature of the study and must sign an informed consent document.
Descripción

Study Protocol Comprehension | Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0162340
UMLS CUI [2]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
serious, unstable somatic illnesses
Descripción

Illness Somatic Unstable Serious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C2986476
UMLS CUI [1,3]
C0443343
UMLS CUI [1,4]
C0205404
illnesses associated with weight gain including renal and endocrine diseases
Descripción

Illness Associated with Weight Gain | Kidney Diseases | Endocrine System Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0043094
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0014130
weight change greater than 3 kg in the preceding three months
Descripción

Body Weight Change Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005911
UMLS CUI [1,2]
C1265611
weight gain less than 1.5 kg in the first 4 weeks
Descripción

Weight Gain Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0043094
UMLS CUI [1,2]
C1265611
Volver a la parte superior de la página

Similar models

Eligibility Schizophrenia NCT00169702

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia
Item
diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv) criteria for schizophrenia
boolean
C0036341 (UMLS CUI [1])
Age
Item
ages between 18 and 65
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Weight Gain Quantity
Item
weight gain of at least 1.5 kg in the first 4 weeks
boolean
C0043094 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Weight maintenance regimen Participation Comprehension
Item
a sufficient understanding to participate adequately in the weight management program
boolean
C0920298 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
Protocol Compliance
Item
patients must agree to cooperate with all tests and examinations required by the protocol.
boolean
C0525058 (UMLS CUI [1])
Study Protocol Comprehension | Informed Consent
Item
each patient must understand the nature of the study and must sign an informed consent document.
boolean
C2348563 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Illness Somatic Unstable Serious
Item
serious, unstable somatic illnesses
boolean
C0221423 (UMLS CUI [1,1])
C2986476 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
C0205404 (UMLS CUI [1,4])
Illness Associated with Weight Gain | Kidney Diseases | Endocrine System Diseases
Item
illnesses associated with weight gain including renal and endocrine diseases
boolean
C0221423 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0043094 (UMLS CUI [1,3])
C0022658 (UMLS CUI [2])
C0014130 (UMLS CUI [3])
Body Weight Change Quantity
Item
weight change greater than 3 kg in the preceding three months
boolean
C0005911 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Weight Gain Quantity
Item
weight gain less than 1.5 kg in the first 4 weeks
boolean
C0043094 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial